Search

Search Constraints

You searched for: Author/Creator Montero, Samuel

Search Results

1. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Issue 9 (September 2022)

2. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption. (24th April 2016)

3. Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption. (24th April 2016)

4. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. Issue 9 (September 2022)